TICKER INTELLIGENCE

Nutrien ($NTR)

NYSE/NASDAQ: NTR

Company & Legislative Profile

Nutrien is a publicly traded company in the Agriculture sector. This company operates across Agriculture and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 4 active Congressional signals mentioning Nutrien, including 4 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.

Nutrien ($NTR) is currently facing 4 active congressional signals tracked by HillSignal. With 2 bullish, 2 neutral, and 0 bearish signals, covering 3 sectors. Key sectors affected include Agriculture, Manufacturing and Materials. Recent major catalysts include Securing American Agriculture Act and Plant Biostimulant Act of 2025. Below is the complete tracker of government activity affecting Nutrien’s market performance.

4

Total Signals

2.5/10

Avg Impact

2

Bullish Signals

0

Bearish Signals

Recent Congressional Signals for Nutrien ($NTR)

The Checkoff Transparency Act (HR7851) is a procedural transparency bill requiring USDA to publish existing audit and budget documents for commodity checkoff programs. It alters no market mechanisms, no revenue streams, and no funding for any publicly traded company. No market impact is expected.

HR7851Congressional Bill

The Securing American Agriculture Act (S912) is an early-stage bill requiring annual USDA reports on U.S. dependency on Chinese agricultural inputs, including equipment and fertilizers. With no authorized funding and only committee referral, the bill creates a long-term policy signal but has zero near-term market impact. Real market data shows mixed trading: Deere ($DE, $584.91) is up 3.84% in 30 days, while Mosaic ($MOS, $23.39) has declined 8.27% over the same period, reflecting broader sector headwinds independent of this bill.

S912Congressional Bill

The Plant Biostimulant Act of 2025 (HR3783) defines biostimulants federally and exempts them from FIFRA pesticide registration, reducing regulatory costs for companies with biological product pipelines (FMC, NTR, MOS). The bill is in early legislative stages (referred to committee) with no authorized funding, limiting near-term market impact. Current stock prices reflect broader market trends rather than bill-specific catalysts: FMC at $15.61 (+4.91% over 7 days but -9.35% over 30), NTR at $75.15 (+5% 7-day), and MOS at $23.28 (-3% 7-day).

HR3783Congressional Bill

HR7716 (Tariff Free Farming Act) is an early-stage bill blocking new tariffs on imported agricultural inputs from normal trade relations countries. At referral stage with low near-term passage probability, its market impact is procedural. Fertilizer importers $NTR and downstream processors $ADM see a marginal bullish effect, while domestic producers $MOS and $CF lose a potential tariff-driven pricing tailwind.

HR7716Congressional Bill

Understanding These Signals

Get Full Access to Nutrien ($NTR) Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →